Keyword search

Description: Previous research has found variability in cancer incidence and cancer-related outcomes according to place of residence. This study examined geographic variability in the incidence and mortality of breast cancer among females in Canada, using data from the 2021 Canadian Cancer Registry (breast cancer incidence) and the Canadian Vital Statistics – Death database (breast cancer mortality). Age-standardized incidence rates (ASIRs) and age-standardized mortality rates (ASMRs) per 100,000 females per year and their rate ratios were calculated, as well as age group-specific and age-standardized stage-specific incidence rates, and examined across provinces and territories, community sizes, and peer groups (i.e., clusters of health regions with similar socioeconomic and demographic characteristics).

Description: Breast cancer is the most commonly diagnosed cancer among women in Canada. Breast density substantially influences breast cancer risk and mammography performance. However, OncoSim-Breast, a Canadian microsimulation model representing breast cancer control, including cancer onset, screening, and survival, has not previously explicitly accounted for breast density. This study describes the incorporation of density-specific parameters—prevalence, relative risk of breast cancer, and digital mammography performance (sensitivity and specificity)—using data from five Canadian provinces, into the OncoSim-Breast model. Calibration experiments and internal validations were conducted to ensure the updated OncoSim-Breast model aligned with observed data from the Canadian Cancer Registry.

Description: This infographic explores trends in Canadians’ weight over time, as well as how obesity may impact health.

Description: Body mass index (BMI) is commonly used to estimate obesity prevalence; however, reliance on BMI alone can lead to an incomplete understanding of obesity’s impact on health. In line with the 2025 recommendations of the Lancet Diabetes & Endocrinology Commission, this study used measured and self-reported data from the 2016 to 2019 Canadian Health Measures Survey to combine population-level measures of excess adiposity with indicators of physiological dysfunction and activity limitation across eight body system domains. Clinical and preclinical obesity were characterized by excess adiposity and progressive obesity-related impairment among Canadian adults.

Description: Cardiovascular health measures of the household population, by sex and age group.

Description:

Number and rate of new cancer cases diagnosed annually from 1992 to the most recent diagnosis year available. Included are all invasive cancers and in situ bladder cancer with cases defined using the Surveillance, Epidemiology and End Results (SEER) Groups for Primary Site based on the World Health Organization International Classification of Diseases for Oncology, Third Edition (ICD-O-3). Random rounding of case counts to the nearest multiple of 5 is used to prevent inappropriate disclosure of health-related information.

Description:

The number of new cases, age-standardized rates and average age at diagnosis of cancers diagnosed annually from 1992 to the most recent diagnosis year available. Included are all invasive cancers and in situ bladder cancer with cases defined using the Surveillance, Epidemiology and End Results (SEER) Groups for Primary Site based on the World Health Organization International Classification of Diseases for Oncology, Third Edition (ICD-O-3). Cancer incidence rates are age-standardized using the direct method and the final 2011 Canadian postcensal population structure. Random rounding of case counts to the nearest multiple of 5 is used to prevent inappropriate disclosure of health-related information.

Description: Number of deaths caused by certain infectious and parasitic diseases, by age group and sex, 2000 to most recent year.

Description: Number of deaths caused by neoplasms, by age group and sex, 2000 to most recent year.

Description: Number of deaths caused by endocrine, nutritional and metabolic diseases, by age group and sex, 2000 to most recent year.

Description: Age-standardized five-year relative survival ratios for all cancers for 3 years of cases from 1992 to 2001, by sex, for Canada (excluding Quebec) and selected provinces.

Description: Five-year relative survival ratios for all cancers for 1 year of cases from 1992 to 2003, by sex, for selected provinces.

Description: Five-year relative survival ratios for all cancers for 3 years of cases from 1992 to 2001, by sex, for selected provinces.

Description: The Cancer Survival Statistics tables provide site-specific five-year observed and relative survival estimates for cases diagnosed from 1992 onwards. In addition to age-specific and age-standardized national (excl. Quebec) estimates, all ages (15 to 99 years) and age-standardized provincial estimates are available.

Description:

The Cancer Incidence in Canada tables provide information on the number of new cases and rates of cancer tumours and patients from 1992 onwards by five-year age-groups and sex for all Canadian provinces and territories as well as information on the primary ICD-O-3 sites of cancer.

Description:

This table contains 600 series, with data for years 1997 - 1997 (not all combinations necessarily have data for all years). This table contains data described by the following dimensions (Not all combinations are available): Geography (15 items: Canada; Prince Edward Island; Newfoundland and Labrador; Nova Scotia ...), Sex (3 items: Both sexes; Females; Males ...), Selected sites of cancer (ICD-9) (4 items: Colorectal cancer; Prostate cancer; Lung cancer; Female breast cancer ...), Characteristics (5 items: Relative survival rate for cancer; High 95% confidence interval; relative survival rate for cancer; Number of cases; Low 95% confidence interval; relative survival rate for cancer ...).

Description:

This table contains 45 series, with data for years 1997 - 2003 (not all combinations necessarily have data for all years). This table contains data described by the following dimensions (Not all combinations are available): Geography (5 items: Nova Scotia; New Brunswick; Alberta; British Columbia ...), Sex (3 items: Both sexes; Females; Males ...), Characteristics (3 items: 365-day net survival rate for acute myocardial infarction (AMI);High 95% confidence interval; 365-day net survival rate for acute myocardial infarction (AMI);Low 95% confidence interval; 365-day net survival rate for acute myocardial infarction (AMI) ...).

Description:

This table contains 45 series, with data for years 1996 - 2003 (not all combinations necessarily have data for all years). This table contains data described by the following dimensions (Not all combinations are available): Geography (5 items: Prince Edward Island; Nova Scotia ...), Sex (3 items: Both sexes; Males; Females ...), Characteristics (3 items: 180-day net survival rate for all stroke; Low 95% confidence interval; 180-day net survival rate for all stroke; High 95% confidence interval; 180-day net survival rate for all stroke ...).

Description:

This table contains 5280 series, with data for years 2001 - 2003 (not all combinations necessarily have data for all years). This table contains data described by the following dimensions (Not all combinations are available): Geography (160 items: Canada; Central Regional Integrated Health Authority; Newfoundland and Labrador; Eastern Regional Integrated Health Authority; Newfoundland and Labrador; Newfoundland and Labrador ...), Sex (3 items: Both sexes; Males; Females ...), Selected sites of cancer (ICD-O-3) (5 items: All invasive primary cancer sites (including in situ bladder);Colon; rectum and rectosigmoid junction cancer; Female breast cancer; Bronchus and lung cancer ...), Characteristics (3 items: Cancer incidence; Low 95% confidence interval; cancer incidence; High 95% confidence interval; cancer incidence ...).

Description:

This table contains 359856 series, with data for years 2005 - 2005 (not all combinations necessarily have data for all years). This table contains data described by the following dimensions (Not all combinations are available): Geography (160 items: Canada; Newfoundland and Labrador; Eastern Regional Integrated Health Authority; Newfoundland and Labrador; Central Regional Integrated Health Authority; Newfoundland and Labrador ...) Age group (14 items: Total; 12 years and over; 12 to 14 years; 15 to 19 years; 12 to 19 years ...) Sex (3 items: Both sexes; Females; Males ...) Injuries (7 items: Total population for the variable injuries; No injuries in the past 12 months; Injuries in the past 12 months; sought medical attention; Injuries in the past 12 months; did not seek medical attention ...) Characteristics (8 items: Number of persons; Coefficient of variation for number of persons; High 95% confidence interval; number of persons; Low 95% confidence interval; number of persons ...).

Description: Previous research has found variability in cancer incidence and cancer-related outcomes according to place of residence. This study examined geographic variability in the incidence and mortality of breast cancer among females in Canada, using data from the 2021 Canadian Cancer Registry (breast cancer incidence) and the Canadian Vital Statistics – Death database (breast cancer mortality). Age-standardized incidence rates (ASIRs) and age-standardized mortality rates (ASMRs) per 100,000 females per year and their rate ratios were calculated, as well as age group-specific and age-standardized stage-specific incidence rates, and examined across provinces and territories, community sizes, and peer groups (i.e., clusters of health regions with similar socioeconomic and demographic characteristics).

Description: Breast cancer is the most commonly diagnosed cancer among women in Canada. Breast density substantially influences breast cancer risk and mammography performance. However, OncoSim-Breast, a Canadian microsimulation model representing breast cancer control, including cancer onset, screening, and survival, has not previously explicitly accounted for breast density. This study describes the incorporation of density-specific parameters—prevalence, relative risk of breast cancer, and digital mammography performance (sensitivity and specificity)—using data from five Canadian provinces, into the OncoSim-Breast model. Calibration experiments and internal validations were conducted to ensure the updated OncoSim-Breast model aligned with observed data from the Canadian Cancer Registry.

Description: This infographic explores trends in Canadians’ weight over time, as well as how obesity may impact health.

Description: Body mass index (BMI) is commonly used to estimate obesity prevalence; however, reliance on BMI alone can lead to an incomplete understanding of obesity’s impact on health. In line with the 2025 recommendations of the Lancet Diabetes & Endocrinology Commission, this study used measured and self-reported data from the 2016 to 2019 Canadian Health Measures Survey to combine population-level measures of excess adiposity with indicators of physiological dysfunction and activity limitation across eight body system domains. Clinical and preclinical obesity were characterized by excess adiposity and progressive obesity-related impairment among Canadian adults.

Description: Has Canada become a sedentary nation? Health data have never been more accessible. We have smart watches to count our steps, notifications about our screen times and apps to track our daily diets. Despite the futuristic tech, researchers are growing concerned. And they’re especially concerned about young Canadians. Today we sat down with Rachel Colley, a senior health researcher at StatCan for a deep dive into Canada’s obesity, physical activity and screen time trends. And the new data from the Canadian Health Measures survey may surprise you.

Description: This infographic highlights breast cancer statistics from the Canadian Cancer Registry (CCR). Breast cancer incidence is presented, as well as survival rates for women in Canada.

Description: Globally, cervical cancer is one of the most common cancers, yet it is largely preventable. Switching methods for primary screening from cytology testing, via Pap test, to human papillomavirus (HPV) testing is a component of that prevention. OncoSim-Cervix, a Canadian cervical cancer microsimulation model, assesses the long-term effects of HPV vaccination and screening interventions. This study projects the impact of differing roll-out strategies for HPV primary testing for cervical cancer screening in Canada.

Description: Release published in The Daily – Statistics Canada’s official release bulletin

Description: Release published in The Daily – Statistics Canada’s official release bulletin

Description: Metabolic syndrome (MetS) is a clustering of multiple risk factors, including abdominal obesity (or high waist circumference), elevated triglycerides, low high-density lipoprotein cholesterol, high fasting blood glucose, and high blood pressure. MetS is an important contributor to cardiovascular disease and type 2 diabetes. Research indicates that MetS doubles the risk of cardiovascular disease and increases the risk of diabetes fivefold. Using the most recent nationally representative data from the Canadian Health Measures Survey, this study provides an updated prevalence of MetS and its components among Canadian adults aged 18 to 79 years by age group and sex.

Description:

The Record Linkage Overview describes the process used in annual internal record linkage of the Canadian Cancer Registry. The steps include: preparation; pre-processing; record linkage; post-processing; analysis and resolution; resolution entry; and, resolution processing.

Description:

The compendium of Canadian Cancer Registry procedures manuals set out the rules for reporting cancer data to the CCR for all provincial and territorial cancer registries.

Description:

The Record Linkage Overview describes the process used in annual internal record linkage of the Canadian Cancer Registry. The steps include: preparation; pre-processing; record linkage; post-processing; analysis and resolution; resolution entry; and, resolution processing.

Description:

The User Guide to Record Linkage Feedback Reports C1 and C2 is intended for the users of the reports. The reports were developed to facilitate the exchange of information and decisions between the Canadian Cancer Registry and the Provincial and Territorial Cancer Registries.

Description:

The User Guide to Record Linkage Feedback Reports C1 and C2 is intended for the users of the reports. The reports were developed to facilitate the exchange of information and decisions between the Canadian Cancer Registry and the Provincial and Territorial Cancer Registries.

Description:

The user guide to Death Clearance Feedback Reports is intended for users of the feedback reports. The feedback reports were developed to facilitate the exchange of information and decisions between the Canadian Cancer Registry and the Provincial and Territorial Cancer Registries.

Description:

The Record Linkage Overview describes the process used in annual internal record linkage of the Canadian Cancer Registry. The steps include: preparation; pre-processing; record linkage; post-processing; analysis and resolution; resolution entry; and, resolution processing.

Description:

The Death Clearance Overview document describes the Death Clearance module of the Canadian Cancer Registry, its structure, its function and its role in the operation of the national cancer registry. Inputs and outputs are listed and briefly described, as well as the different steps constituting the Death Clearance process.

Description:

The Guidelines for Abstracting and Determining Death Certificate Only Cases are intended for use by all provincial and territorial cancer registries during their Death Clearance Process. The guidelines should be used when performing a comparison between the Death Certificate Notification and the cancer registry database.

Description:

This document examines the functional limitations, physical, emotional and social, related to the musculoskeletal conditions having the largest impact on the health of Canadians. These functional limitations are described and classified using the Classification and Measurement System of Functional Health (CLAMES).

These descriptions and classifications are the first step in a new approach to measuring the health of Canadians that examines what factors are adversely affecting population health and how to address them. This document also provides health professionals, advocacy groups, and individual Canadians with an overview of how living with certain musculoskeletal conditions affects day-to-day functioning.